期刊文献+

瑞替普酶(reteplase)在海带中表达的鉴定分析 被引量:3

Identification of Reteplase Expressed in Laminaria Japonica
下载PDF
导出
摘要 为验证本实验室构建的瑞替普酶(reteplase,r-PA)基因是否成功转入海带,本文通过FAPA、PCR、Southern blotting和Western blotting等方法分别从体外纤溶活性、DNA的整合以及目的蛋白的表达等三个方面进行鉴定,并运用固定化金属离子亲和层析对表达的蛋白进行了初步分离纯化。FAPA结果表明转基因海带蛋白具有溶栓活性,PCR和Southern Blotting显示在1 100 bp处有特异性条带,Western blotting在39 ku处有蛋白条带,证明r-PA基因已成功转入海带而且获得稳定表达,海带中表达的r-PA不需复性就具有溶栓活性,同时说明在r-PA N端设计的(His)6有助于我们利用亲和层析分离纯化目的蛋白。 In order to identify if the gene of reteplase(r-PA) has been successfully transferred into the La minaria Japonica , the r-PA was studied on the level of activity, the integration of DNA and expression of protein with the methods of FAPA, PCR, Southern blotting and Western blotting. At the same time, the expression r-PA protein was initially purified by the Ni-chelating chromatography. The results showed that the supernatant of the grinded La minaria Japonica has the activity of thrombolysis. PCR and Southern blotting displayed that there was a special bind at the position of 1100bp. SDS-PAGE and Western blotting pictured that there was a visible band at the position of 39KD. All these identified that the gene of reteplase had been successfully transformed into La minaria Japonica and had expressed stably, and the r-PA protein had the activity of Thrombolysis without the need of renaturation. It is also demonstrated in this paper that the (His)6 at the end of N-ter minal had an advantage to purify the r-PA protein easily.
出处 《药物生物技术》 CAS CSCD 2006年第4期265-270,共6页 Pharmaceutical Biotechnology
基金 江苏省高科技项目(No.BG2002318)
关键词 海带 瑞替普酶 鉴定 La minaria Japonica, Reteplase(r-PA), Identification
  • 相关文献

参考文献13

  • 1Moffat A S.Exploring transgenic plants as a new vaccine source[J].Science,1995,268:658-660.
  • 2Mason H S,Arntzen C J.Transgenic plants as vaccine production systems[J].Trends Biotechnol,1995,13(9):388-392.
  • 3Kohnert U,Rudolph R,Verheijen JH,et al.Biochemical properties of the kringle 2 and protease domains are maintained in the refolding t-PA deletion variant BM 06.022[J].Protein Engineering,1992,5 (1):93-100.
  • 4Noble S.Reteplase:a review of its pharmacological properties and clinical efficacy in the management of acute myocardial in faction[J].Drugs,1996,52(4):589.
  • 5Davidson S.New clot busters threaten Genentech's t-PA[J].Nature Biotech,1997,15:405.
  • 6孙石静,张新元,孙雄华,廖建民,沈子龙.r-PA真核表达载体的构建与鉴定[J].药物生物技术,2005,12(3):152-157. 被引量:5
  • 7王结义.组织型纤溶酶原激活剂的提纯和鉴定[J].上海医科大学学报,1987,14(3):179-182.
  • 8Deogny L.Improved Fibrin Flate Method for Fibrinolytic Activity Measurement:Use of Bentonite precipitation and Agar Solidification[J].Clin Clim Acta,1975,60 (1):85 89.
  • 9Granelli piperno A,Reich E.A study of proteases and prote ase-inhibitor complexes in biological fluids[J].J Exp Med,1978,148(1):223-234.
  • 10Bradford M M.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein dye binding[J].Anal Biochem,1976,72 (1):248-254.

二级参考文献3

  • 1Kohnert U, Rudolph R, Verheijen J H, et al. Biochemical properties of the kringle 2 and protease domains are maintained in the refolding t-PA deletion variant BM 06. 022[J].Protein Engineering, 1992,5(1):93.
  • 2Verstraete M, Lijnen H R, Collen D. Thrombolytic agents in development[J]. Drugs, 1995, 50(1):29.
  • 3Wild T F, Bernard A, Spehner D, et al. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice[J].J Gen Virol, 1992,73(2):359.

共引文献10

同被引文献23

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部